XENE
USDXenon Pharmaceuticals Inc. Common Shares
Preço em tempo real
Gráfico de preços
Métricas-chave
Métricas de mercado
Abertura
$39.740
Máximo
$40.450
Mínimo
$37.625
Volume
0.18M
Fundamentos da empresa
Capitalização de mercado
3.0B
Setor
Biotecnologia
País
Canada
Estatísticas de negociação
Volume médio
0.79M
Bolsa de valores
NGM
Moeda
USD
Faixa de 52 semanas
Notícias relacionadas
RBC Capital Maintains Outperform on Xenon Pharmaceuticals, Raises Price Target to $58
RBC Capital analyst Brian Abrahams maintains Xenon Pharmaceuticals with a Outperform and raises the price target from $55 to $58.
Wells Fargo Maintains Overweight on Xenon Pharmaceuticals, Lowers Price Target to $44
Wells Fargo analyst Benjamin Burnett maintains Xenon Pharmaceuticals with a Overweight and lowers the price target from $48 to $44.
Needham Reiterates Buy on Xenon Pharmaceuticals, Maintains $55 Price Target
Needham analyst Serge Belanger reiterates Xenon Pharmaceuticals with a Buy and maintains $55 price target.
Xenon to Report Q3 2025 Financial Results on November 3, 2025
VANCOUVER, British Columbia and BOSTON, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (NASDAQ:XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and
Ações relacionadas
Mantenha-se atualizado
Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.